MMP9 and Stroke: During stroke, rapid activation of the proteolytic enzyme, matrix-metalloproteinase-9 (MMP9) leads to degradation of the neurovascular unit and compromise of the blood-brain barrier (BBB) (Gasche et al., 1999; Planas et al., 2001; Montaner, 2003; Fukuda et al., 2004).